This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Everest Group (EG) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Everest Group (EG) delivered earnings and revenue surprises of -13.54% and 4.53%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Will Lower General Insurance Profit Affect AIG's Q1 Earnings?
by Zacks Equity Research
American International's first-quarter earnings are likely to have witnessed a higher combined ratio in General Insurance.
Earnings Preview: Hamilton Insurance (HG) Q1 Earnings Expected to Decline
by Zacks Equity Research
Hamilton Insurance (HG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Flushing Financial (FFIC) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Flushing Financial (FFIC) delivered earnings and revenue surprises of 4.55% and 5.49%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
ROOT Stock Surges 109% YTD, Drops 16% From 52-Week High: Time to Buy?
by Tanuka De
ROOT envisions being the largest and most profitable company in the industry. Let us delve deeper to find out what to do with ROOT stock now.
Aflac Gears Up for Q1 Earnings: Will AFL Quack or Crack?
by Zacks Equity Research
AFL's first-quarter earnings are likely to have benefited from growing total adjusted revenues in Aflac U.S.
Allstate to Report Q1 Earnings: Can Higher Premiums Save the Day?
by Zacks Equity Research
ALL's first-quarter earnings are likely to have benefited from growing underwriting income from the Auto brand.
Is a Beat in the Cards for Cboe Global This Earnings Season?
by Zacks Equity Research
CBOE's Q1 results are likely to reflect solid index options growth, disciplined expense management and healthy trading volumes.
Lemonade (LMND) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Lemonade (LMND) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Arthur J. Gallagher Pull Off a Surprise in Q1 Earnings?
by Zacks Equity Research
AJG's Q1 results are likely to reflect solid retention, higher renewal premiums, improved investment income, as well as strategic buyouts.
Will Intercontinental Exchange Pull Off a Surprise in Q1 Earnings?
by Zacks Equity Research
ICE's Q1 results are likely to reflect solid index business, growth in ICE Global Network offering and strong retention rate of existing customers.
Will Catastrophe Loss Weigh on Everest Group's Q1 Earnings?
by Zacks Equity Research
EG's Q1 results are likely to reflect higher earned premiums and strong core fixed income investment returns, offset by higher catastrophe losses.
Goosehead Insurance (GSHD) Tops Q1 Earnings Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of 13.04% and 3.41%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
PLMR Rallies 40% YTD: Time to Buy the Stock Despite Premium Valuation?
by Tanuka De
Palomar is poised for growth, banking on the strength of its new business generation, strong retention rates, risk transfer strategy and solid capital position.
ROOT vs. LMND: Which InsurTech Has More Upside Potential?
by Tanuka De
Let's find out which InsureTech is a safe investment option, ROOT or LMND.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
ROOT Zooms Past S&P 500: Should You Buy Despite Premium Valuation?
by Tanuka De
Let us delve deeper to find out what to do with ROOT stock now.
PLMR Stock Outperforms Industry, Trades at a Premium: Should You Buy?
by Tanuka De
Palomar is poised for growth, banking on the strength of new business generated, strong retention rates, risk transfer strategy and solid capital position.
Lemonade Q4 Loss Narrower Than Expected, Revenues Rise Y/Y
by Zacks Equity Research
LMND's Q4 2024 results reflect an increase in net earned premiums and an increase in investment income, offset by higher expenses.
Lemonade (LMND) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Lemonade (LMND) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Lemonade (LMND) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 30% and 2.65%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of 92.68% and 20.70%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Curious about Lemonade (LMND) Q4 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Lemonade (LMND), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.